Skip to content

TERUMO SS-10L2125Recalls & reported problems

Terumo (Philippines) Corporation · TERUMO Syringe with Needle · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
3
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 34806017511358), received between Dec 6, 2024 and Jun 27, 2025 — classified as 3 injuries.

The most frequently reported specific device problem is “Crack” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 2 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 1 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Crack2
  • Loose or Intermittent Connection1

Patient problems

  • Numbness2
  • Rash2
  • Skin Burning Sensation2
  • Swelling/ Edema2
  • Insufficient Information1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • InjuryJun 27, 2025Loose or Intermittent Connection; Loose or Intermittent Connection

    IT WAS REPORTED PER JANSSEN CANADA (B)(6) THAT THE PATIENT PRESENTED TODAY TO RECEIVE A SIMPONI INFUSION. HE MENTIONED HAVING GENERALIZED PAIN WHEN HE EATS TOO MUCH SUGAR. WHILE PREPARING THE MEDICATION, I WITHDREW 4 ML FROM THE FIFTH VIAL OF MEDICATION. WHEN I CAME TO WITHDRAW 4 ML FROM ANOTHER VIAL WITH THE SAME SYRINGE, I INSERTED THE NEEDLE INTO THE RUBBER STOPPER. AS I WAS ABOUT TO WITHDRAW, THE NEEDLE PARTIALLY DETACHED FROM THE SYRINGE, AND A SMALL AMOUNT OF MEDICATION THAT WAS IN THE SYRINGE AND VIAL CAME OUT AS A SPRAY. THE MEDICATION ENDED UP ON MY FACE (FOREHEAD AND CHIN) AS WELL AS ON MY FOREARMS. I IMMEDIATELY WASHED MY FACE AND HANDS IN THE SINK WITH WARM WATER AND SOAP. THE AIC WAS NOTIFIED, AND A REPORT WAS MADE. WE MANAGED TO ADMINISTER THE PRESCRIBED DOSE TO THE PATIENT WITH THE EXCESS MEDICATION IN THE OTHER VIALS. THE RPN EXPERIENCE SPLASH EXPOSURE REACTION, AND ORAL BENADRYL WAS TAKEN.

    Patient problems: Insufficient Information

    MAUDE report 22352228 ↗
  • InjuryDec 6, 2024Crack; Crack

    THE USER FACILITY REPORTED A PATIENT SCHEDULED FOR IUD REPLACEMENT IN 2 WEEKS. DURING THE PREPARATION OF THE LAST VIAL OF REMICADE, THE VIAL EXPLODED, CAUSING THE MEDICATION TO SPILL ONTO THE NURSE'S FACE, NECK, AND CHEST. UPON CLOSER INSPECTION, A CRACK WAS FOUND IN THE SYRINGE, WHICH LED TO THE LEAKAGE. DESPITE THIS, THE PATIENT RECEIVED THE FULL DOSE AS ONLY A PORTION OF THE VIAL WAS NEEDED. THE NURSE EXPERIENCED A SWOLLEN AND NUMB FACE, BURNING LIPS, AND A RASH ON HER FACE AND CHEST. ORAL BENADRYL WAS TAKEN TO ADDRESS THESE SYMPTOMS. ADDITIONAL INFORMATION RECEIVED ON 12 NOV 2024: THE NURSE IS NOW STABLE AND HAS SEEN THEIR FAMILY DOCTOR, WHO PRESCRIBED PREDNISONE AND BLEXTEN. THE ACTUAL PATIENT WAS NOT IMPACTED IN ANY WAY.

    Patient problems: Numbness; Rash; Skin Burning Sensation; Swelling/ Edema

    MAUDE report 20873088 ↗
  • InjuryDec 6, 2024Crack; Crack

    THE USER FACILITY REPORTED A PATIENT SCHEDULED FOR IUD REPLACEMENT IN 2 WEEKS. DURING THE PREPARATION OF THE LAST VIAL OF REMICADE, THE VIAL EXPLODED, CAUSING THE MEDICATION TO SPILL ONTO THE NURSE'S FACE, NECK, AND CHEST. UPON CLOSER INSPECTION, A CRACK WAS FOUND IN THE SYRINGE, WHICH LED TO THE LEAKAGE. DESPITE THIS, THE PATIENT RECEIVED THE FULL DOSE AS ONLY A PORTION OF THE VIAL WAS NEEDED. THE NURSE EXPERIENCED A SWOLLEN AND NUMB FACE, BURNING LIPS, AND A RASH ON HER FACE AND CHEST. ORAL BENADRYL WAS TAKEN TO ADDRESS THESE SYMPTOMS. ADDITIONAL INFORMATION RECEIVED ON 12 NOV 2024: THE NURSE IS NOW STABLE AND HAS SEEN THEIR FAMILY DOCTOR, WHO PRESCRIBED PREDNISONE AND BLEXTEN. THE ACTUAL PATIENT WAS NOT IMPACTED IN ANY WAY.

    Patient problems: Numbness; Rash; Skin Burning Sensation; Swelling/ Edema

    MAUDE report 20873058 ↗

Other Syringe, piston devices

All Syringe, piston devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page